![](https://investorshub.advfn.com/uicon/453436.png?cb=1502895800)
Saturday, March 04, 2017 10:47:33 PM
The U.S. Drug Enforcement Administration will reclassify marijuana as a “Schedule Three” drug on March 15, 2017, essentially legalizing medicinal cannabis in all 50 states with a doctor’s prescription, said a DEA lawyer with knowledge of the matter.
The DEA Lawyer had told the lawyer representing a DEA informant of the DEA’s plan to legalize medicinal cannabis nationwide on March 15, 2017. When questioned by our reporter, the DEA lawyer felt compelled to admit the truth to him as well.
“Whatever the law may be in California, Arizona or Utah or any other State, because of Federal preemption this will have the effect of making THC products legal with a prescription, in all 50 states,” the DEA attorney told the Observer. Federal Preemption is a legal doctrine that where the US Government regulates a particular field, State and local laws are overridden and of no effect.
He explained that “there are five DEA schedules. Nothing on Schedule One is ever legal, and that is where Cannabis is today. Schedule Three drugs are available with a prescription.”
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM